BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 47 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $7,875,000 | -0.5% | 6,000,000 | -20.0% | 0.36% | -11.4% |
| Q1 2020 | $7,916,000 | -0.1% | 7,500,000 | +2.7% | 0.40% | +25.5% |
| Q4 2019 | $7,920,000 | +5.2% | 7,300,000 | 0.0% | 0.32% | +0.3% |
| Q3 2019 | $7,528,000 | -8.4% | 7,300,000 | 0.0% | 0.32% | -11.1% |
| Q2 2019 | $8,214,000 | -1.1% | 7,300,000 | 0.0% | 0.36% | -4.8% |
| Q1 2019 | $8,303,000 | +2.3% | 7,300,000 | 0.0% | 0.38% | -10.2% |
| Q4 2018 | $8,119,000 | -7.2% | 7,300,000 | 0.0% | 0.42% | +6.0% |
| Q3 2018 | $8,749,000 | -7.1% | 7,300,000 | -9.9% | 0.40% | -15.5% |
| Q2 2018 | $9,414,000 | +287.2% | 8,100,000 | +268.2% | 0.47% | +267.2% |
| Q1 2018 | $2,431,000 | -35.5% | 2,200,000 | -37.1% | 0.13% | -68.0% |
| Q4 2013 | $3,769,000 | – | 3,500,000 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCHRODER INVESTMENT MANAGEMENT GROUP | 12,400,000 | $1,340,750,000,000 | 1.66% |
| OAKTREE CAPITAL MANAGEMENT LP | 66,800,000 | $70,446,000 | 1.23% |
| Man Investments (CH) AG | 2,600,000 | $2,743,000 | 1.11% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 8,000,000 | $8,425,000 | 0.81% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 35,763,000 | $38,870,000 | 0.58% |
| Jabre Capital Partners S.A. | 5,900,000 | $6,240,000 | 0.44% |
| SSI INVESTMENT MANAGEMENT LLC | 3,039,000 | $3,198,000 | 0.31% |
| AVIVA PLC | 37,700,000 | $39,724,000 | 0.30% |
| BNP PARIBAS FINANCIAL MARKETS | 3,000,000 | $315,929,984,000 | 0.30% |
| Calamos Advisors LLC | 44,222,000 | $46,596,000 | 0.30% |